Henry Schein (Nasdaq: HSIC ) is expected to report Q1 earnings on May 7. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Henry Schein's revenues will grow 7.4% and EPS will increase 10.2%.
The average estimate for revenue is $2.26 billion. On the bottom line, the average EPS estimate is $1.08.
Last quarter, Henry Schein tallied revenue of $2.41 billion. GAAP reported sales were 2.9% higher than the prior-year quarter's $2.34 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $1.26. GAAP EPS of $1.26 for Q4 were 9.6% higher than the prior-year quarter's $1.15 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 27.5%, 40 basis points worse than the prior-year quarter. Operating margin was 7.5%, 50 basis points better than the prior-year quarter. Net margin was 4.7%, 20 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $9.52 billion. The average EPS estimate is $4.87.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 93 members out of 105 rating the stock outperform, and 12 members rating it underperform. Among 32 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 30 give Henry Schein a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Henry Schein is hold, with an average price target of $79.23.
Is Henry Schein the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Henry Schein to My Watchlist.